How is the Theravance Biopharma Inc today?

The Theravance Biopharma Inc today is trading in the green, up by 0.64% at 9.45.

How has Theravance Biopharma Inc performed historically?

The Theravance Biopharma Inc is currently trading up 0.64% on an intraday basis in the past week the index rose 7.39%. The index has been down -3.08% in the past quarter and rose 1.72% in the past year. You can view this in the overview section.

What is Theravance Biopharma Inc Annual Revenue?

Theravance Biopharma Inc Annual Revenue rose 12.12%, in the last year to $64.38 M. Its sector's average revenue growth for the last fiscal year was 8.75%.

What is Theravance Biopharma Inc Annual Net Profit?

Theravance Biopharma Inc Annual Net Profit fell 2.22% in the last year to $56.42 M. Its sector's average net profit growth for the last fiscal year was -11.16%.

What is Theravance Biopharma Inc Price to Earning Ratio?

Theravance Biopharma Inc Price to Earning Ratio is -8.1, which is negative.

What is Theravance Biopharma Inc Stock Price?

Theravance Biopharma Inc Stock Price rose 1.72% and underperformed its sector by 12.16% in the past year.

What is Theravance Biopharma Inc Quarterly Revenue?

Theravance Biopharma Inc Quarterly Revenue rose 6.1% YoY to $15.39 M. Its sector's average revenue growth YoY for the quarter was 3.13%.

What is Theravance Biopharma Inc Quarterly Net profit?

Theravance Biopharma Inc Quarterly Net profit fell 16.42% YoY to $13.58 M. Its sector's average net profit growth YoY for the quarter was -200.49%.

What is Theravance Biopharma Inc Debt to Equity Ratio?

Theravance Biopharma Inc Debt to Equity Ratio of 0.28 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Theravance Biopharma Inc Return on Equity(ROE)?

Theravance Biopharma Inc Return on Equity(ROE) for the last financial year was -29.04%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Theravance Biopharma Inc Mutual Fund Holding?

Theravance Biopharma Inc Mutual Fund Holding decreased by 1.29% in the last quarter to 24.04.

What is Theravance Biopharma Inc Promoter Share Holding?

Theravance Biopharma Inc Promoter Share Holding increased by 0.34% in the most recent quarter to 5.53%.

What is Theravance Biopharma Inc Interest Coverage Ratio?

Theravance Biopharma Inc Interest Coverage Ratio is -16.52, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Theravance Biopharma Inc Institutional Holding?

Theravance Biopharma Inc Institutional Holding decreased by 1.63% in the last quarter to 88.39.

Theravance Biopharma Inc XNAS: TBPH

Theravance Biopharma Inc Live Share Price Today, Share Analysis and Chart

Name: Theravance Biopharma Inc: Is Infosys Ltd. worth buying?
Item: Theravance Biopharma Inc
Rating: 1.361736125
Author: Trendlyne DVM scores

Momentum Trap

about

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient...

9.45 0.06 (0.64%)

27.02% Gain from 52W Low

199.9K XNAS Volume

XNAS 20 May, 2025 4:05 PM (EDT)

Board Meeting

The latest board meeting for Theravance Biopharma Inc took place on 20 May 2025, for the purpose of H.C. Wainwright 3rd Annual BioConnect Investor Conference See details

Low Financial Strength

27.8 / 100

Expensive Valuation

6.8 / 100

Technically Neutral

46.6 / 100

Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

1Yr Price target upside is 61%

4 analysts

Theravance Biopharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Theravance Biopharma Inc Live Share Price Today, Share Analysis and Chart

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient...

27.02% Gain from 52W Low

SWOT Analysis

Theravance Biopharma Inc Live Price Chart

Theravance Biopharma Inc FAQ

How is Theravance Biopharma Inc today?

Theravance Biopharma Inc today is trading in the green, and is up by 0.64% at 9.45.

How has Theravance Biopharma Inc performed historically?

Theravance Biopharma Inc is currently trading up 0.64% on an intraday basis. In the past week the stock rose 7.39%. stock has been down -3.08% in the past quarter and rose 1.72% in the past year. You can view this in the overview section.